about
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.Blood dendritic cell frequency declines in idiopathic Parkinson's disease and is associated with motor symptom severityInterleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease.Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophreniaRole of macrophage phospholipase D in natural and CpG-induced antimycobacterial activity.Induction of apoptosis and release of interleukin-1 beta by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection.Effect of age on surface molecules and cytokine expression in human dendritic cells.Increased expression of interleukin-18 receptor in blood cells of subjects with mild cognitive impairment and Alzheimer's disease.The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients.Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.Dendritic cells derived from BCG-infected precursors induce Th2-like immune response.Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury.Amyloid beta peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells.Increased pro-inflammatory response by dendritic cells from patients with Alzheimer's disease.Increased levels of serum IL-18 are associated with the long-term outcome of severe traumatic brain injury.Interleukin-18 produced by peripheral blood cells is increased in Alzheimer's disease and correlates with cognitive impairment.Alzheimer's disease and immune activation: A translational perspective
P50
Q33715791-F707C8EB-7649-4CEB-8AFB-907EE202AEA5Q34775683-44CCE3A1-892D-475A-9FDE-5D48ED707A19Q36227141-09D848C9-724A-40ED-9623-C69ADCA91174Q36281530-2EEF3EC1-9309-4C76-9DF6-FCB342169BDCQ40612413-20B0430E-DFD3-48E0-A6EA-68B1114CB328Q45023866-197A8F36-D102-444D-9701-53365D41C898Q45269938-86EFCF44-259A-47EE-9332-F4CD7411D01BQ45723787-2AA0CD9C-F211-4220-89E9-6DBC007658D2Q45934039-AC45CF7B-A54E-4683-A601-CE7F4FA6A0C1Q46249950-EA2434F0-3435-4822-A4CD-6F26A7D57FAFQ47231079-4250BC57-1F1F-468A-B60C-C8D85C5C7451Q47386680-D0E973A1-6DA8-4E0B-837F-8C68697C445BQ48093117-516E7DDD-A9D7-4425-9BB6-4515C1D584CDQ48328855-E0A431C6-B967-4CC6-AC4A-3D66775C3780Q48965382-BD13B0B8-D6FD-4589-9527-D99486E77FF4Q53389783-EA6164AF-58A7-4393-948A-C2ACE08FD3F1Q58451962-2FCB5910-4A0C-42D9-8526-F47F2E3E1285
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonio Ciaramella
@ast
Antonio Ciaramella
@en
Antonio Ciaramella
@es
Antonio Ciaramella
@nl
Antonio Ciaramella
@sl
type
label
Antonio Ciaramella
@ast
Antonio Ciaramella
@en
Antonio Ciaramella
@es
Antonio Ciaramella
@nl
Antonio Ciaramella
@sl
prefLabel
Antonio Ciaramella
@ast
Antonio Ciaramella
@en
Antonio Ciaramella
@es
Antonio Ciaramella
@nl
Antonio Ciaramella
@sl
P1053
F-1170-2011
P106
P21
P31
P3829
P496
0000-0001-9888-8156
P569
2000-01-01T00:00:00Z